Latest News & Features
Americas
Earlier this month, the first LSIPR roundtable discussion took place in a London hotel, chaired by managing editor Martin Essex, with six invited experts and deputy editor
Ed Conlon taking part. We’ll be publishing a special report on the event but, to whet your appetite, here’s how the discussion began—with a lively debate on the USPTO’s guidelines on patent-eligible subject matter in the wake of the Myriad and Mayo court decisions. 30 September 2014
Americas
The Bay Area of California has one
of the greatest concentrations of life
sciences companies in the world,
but its biotech community is being
threatened by the seemingly
unstoppable rise of large technology businesses. LSIPR spoke to Christopher Stewart, chair, and Robert Eyler,
vice chair, of the new North Bay
Life Science Alliance to find out
how it plans to strengthen the network in the area. 30 September 2014
Americas
Research organisation Horizon Discovery Group has bought Sage Labs in a deal worth almost $50 million, a move that will strengthen its IP portfolio, the company has announced. 29 September 2014
Big Pharma
Increasing numbers of patent challengers are finding the USPTO’s post-grant procedures to be attractive alternatives to district court litigation, write Arlene Chow and Peter Noh. 29 September 2014
Americas
A trade deal between the EU and Canada, due to be signed today if last-minute German concerns can be overcome, would have implications for pharmaceutical IP protection and could raise the cost of drugs in Canada, a report has claimed. 26 September 2014
Americas
A US court has ordered medical technology company Boston Scientific Corporation to pay $309 million to the family of the late physician Michel Mirowski in the latest chapter of their long running patent dispute. 26 September 2014
Asia
Law firm Miller, Canfield, Paddock & Stone has expanded its IP team in China with the appointment of life sciences specialist Kening Li. 24 September 2014
Americas
Generic drug maker Par Pharmaceutical Companies has settled a long running dispute with Salix Pharmaceuticals over its heartburn drug Zegerid (omeprazole/sodium bicarbonate). 23 September 2014
Biotechnology
UK-based cancer drug company Sareum has been granted a patent for an invention forming part of its treatment methods. 22 September 2014